Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
Placement to Institutional and Sophisticated Investors, Appointment of Joint Broker,Issue of Equity & TVR
